πŸ‡ΊπŸ‡Έ FDA
Patent

US 11583556

Modified cells and methods of therapy

granted A61KA61K2239/38A61K40/11

Quick answer

US patent 11583556 (Modified cells and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32